Zdrowie i gospodarka · 06/01/1998

Abbott Laboratories Receives FDA Approval for Tacrolimus II Assay

The FDA has approved Abbott Laboratories' application for premarket approval of the IMx Tacrolimus II Assay, a medical device, under the Federal Food, Drug, and Cosmetic Act, following a notification by the FDA's Center for Devices and Radiological Health on August 26, 1997.